Remission InductionRemission, SpontaneousApoptosisApoptosis Regulatory ProteinsCaspasesCaspase 3Proto-Oncogene Proteins c-bcl-2Inhibitor of Apoptosis ProteinsDNA FragmentationIn Situ Nick-End Labelingbcl-2-Associated X ProteinX-Linked Inhibitor of Apoptosis ProteinCell Line, TumorCell SurvivalApoptosis Inducing FactorCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 9Caspase InhibitorsSignal TransductionAntineoplastic AgentsCaspase 8MitochondriaTumor Suppressor Protein p53Treatment OutcomeRecurrenceFas Ligand ProteinTumor Cells, CulturedCells, CulturedEnzyme ActivationTime FactorsCytochromes cbcl-X ProteinCytarabineFlow CytometryCell ProliferationLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsAnnexin A5Blotting, WesternCell LineProto-Oncogene ProteinsAmino Acid Chloromethyl KetonesCysteine Proteinase InhibitorsCell CycleDose-Response Relationship, DrugEtoposidePoly(ADP-ribose) PolymerasesPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideEnzyme InhibitorsVincristineCell DivisionDoxorubicinTumor Necrosis Factor-alphaTNF-Related Apoptosis-Inducing LigandDaunorubicinReactive Oxygen SpeciesTransfectionJurkat CellsHL-60 CellsCombined Modality TherapyPrednisoneGenes, bcl-2Down-RegulationRNA, Small InterferingCaspase 7Leukemia, MyeloidMembrane Potential, MitochondrialRNA, MessengerCell DeathPrognosisFollow-Up StudiesMembrane GlycoproteinsPhosphorylationPrednisoloneLeukemiaNecrosisMethotrexateReverse Transcriptase Polymerase Chain ReactionUp-Regulationbcl-2 Homologous Antagonist-Killer ProteinTransplantation, AutologousNeoplasm ProteinsCytochrome c GroupNF-kappa BDNA DamageMyeloid Cell Leukemia Sequence 1 ProteinBH3 Interacting Domain Death Agonist ProteinProto-Oncogene Proteins c-aktMice, Inbred C57BLBone Marrow TransplantationLeukemia, Promyelocytic, AcuteAntineoplastic Agents, PhytogenicImmunosuppressive AgentsGene Expression Regulation, NeoplasticLeukemia, LymphoidStaurosporineImmunohistochemistryDrug Resistance, NeoplasmDisease-Free Survival